Himalaya Nutravedics India made its stock market debut on BSE SME on 29 Sept 2026 at ₹118 versus the issue price of ₹106, a +11.32% premium.
Himalaya Nutravedics India IPO Listing
| Metric | Value |
|---|---|
| Issue Price (upper) | ₹106 |
| Listing Price | ₹118 |
| Listing Gain | +11.32% (premium) |
| Listed On | BSE SME · 29 Sept 2026 |
An investor allotted the minimum 1,200 shares (cost ₹1,27,200) is up about ₹14,400 per lot at the listing price, before charges and taxes.
Himalaya Nutravedics India IPO Subscription Status (Final)
| Category | Subscribed (times) | Bids received |
|---|---|---|
| QIB | 1x | ₹4.74 cr |
| NII (HNI) | 2.9x | ₹14 cr |
| Retail | 2.56x | ₹21.34 cr |
| Total | 2.24x | ₹40.08 cr |
Final subscription after the issue closed.
Hold or Book Profit?
In its favour: Integrated manufacturing facility capable of producing multiple dosage forms. To keep in mind: High revenue reliance on Ayurvedic products, accounting for over 90% of sales. A listing pop is a trading outcome; staying invested is a call on the business and its valuation, not the debut price.
More on Himalaya Nutravedics India IPO
- Himalaya Nutravedics India IPO GMP today
- Himalaya Nutravedics India IPO allotment status
- Himalaya Nutravedics India IPO listing price
- Himalaya Nutravedics India IPO listing gain calculator
- All SME IPOs
- Full IPO list with GMP
This article is for information only and is not investment advice. Read the RHP and consider your own risk profile before investing.
Loading comments...